Cardiometabolic Effects of Pecan Snacking in Prediabetes
NCT ID: NCT07235358
Last Updated: 2025-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
147 participants
INTERVENTIONAL
2026-02-01
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiometabolic Effects of Pecans as a Snack
NCT05071807
The Effect of Pecans on Biomarkers of Risk for Cardiovascular Disease and Diabetes
NCT01950806
Diet Quality, Pecans, and Cardiometabolic Health
NCT04487808
The Ability of Pecan Consumption to Improve Vascular Function and Reduce Chronic Disease Risk in Aging Adults
NCT04385537
Diets Enriched With Pecans
NCT04376632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pecan snacking group
Participants will be provided with 1.5 oz/day of pecans and asked to eat these instead of typically consumed snacks higher in saturated fat and added sugars.
Pecan snacking
Replacement of typically consumed snacks with 1.5 oz/day of pecans
Usual diet
Participants will be asked to continue consuming their usual diet. To match attention and resources, participants will be provided with a grocery voucher in approximately equivalent value to the pecans.
Usual diet
Continue with usual diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pecan snacking
Replacement of typically consumed snacks with 1.5 oz/day of pecans
Usual diet
Continue with usual diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prediabetes assessed by an HbA1c of 5.7-6.4% at screening
* BMI 25-40 kg/m2 at screening
* Low habitual nut consumption (\<3.5 oz-eq/week) assessed at the telephone screening
* Regularly eats snacks higher in saturated fat and/or added sugars assessed at the telephone screening
Exclusion Criteria
* Hemoglobin \<13.2 g/dL at screening
* Fasting triglycerides \>350 mg/dL at screening
* ≥10% change in body weight within the 6 months prior to enrollment
* Blood pressure \>140/90 mmHg at screening
* Type 1 or type 2 diabetes
* Prescription of anti-hypertensive, lipid-lowering, or glucose-lowering drugs
* Intake of supplements or over-the-counter medications that affect the outcomes of interest (i.e., lipid, blood pressure, or glucose lowering; vitamin C or multi-vitamins containing vitamin C) and are unwilling to cease during the study period.
* History of liver, kidney, or autoimmune disease
* Prior cardiovascular event (e.g., stroke, heart attack)
* Current pregnancy or intention of pregnancy within the next 12 months
* Lactation within the prior 6 months
* Pecan allergy/intolerance/sensitivity/dislike
* Unwilling/unable to eat 1.5 oz of pecans every day as a snack during the duration of the study
* Antibiotic use within the prior 4 weeks
* Oral steroid use within the prior 4 weeks
* Use of tobacco or nicotine-containing products within the past 6 months
* History of cancer at any site within the past 10 years (eligible if ≥10 years without recurrence) or non-melanoma skin cancer within the past 5 years (eligible if ≥5 years without recurrence)
* Participation in another clinical trial within 60 days of baseline
* Unwilling to contact study staff before enrolling in other health-related research and avoid participating in any research that may interfere with this study.
* Currently following a restricted or weight-loss diet
* Prior bariatric surgery
* Intake of \>14 alcoholic drinks/week and/or not willing to avoid alcohol consumption for 48 hours prior to test visits
* Principal Investigator discretion related to the potential participant's ability to adhere to the study requirements, including being able to come to attend visits
* Does not speak and/or understand English
* Unwilling to refrain from donating blood or plasma during the study
* Weight \<110 lb
* If a potential participant takes thyroid medicine, abnormal thyroid stimulated hormone (TSH) concentration (TSH outside of normal range), or change in dose of thyroid medication within the last 6 months
25 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Pecan Promotion Board
UNKNOWN
Penn State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kristina Petersen PhD, APD, FAHA
Associate Professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.